Advertisment
Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:619

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (538 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   References
   Article Figures

 Article Access Statistics
    Viewed3496    
    Printed80    
    Emailed0    
    PDF Downloaded99    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
IMAGES IN NEPHROLOGY
Year : 2012  |  Volume : 22  |  Issue : 1  |  Page : 62-63
 

Icodextrin and skin rash: Unusual presentation


Department of Nephrology, University of Ottawa, Ottawa, Canada

Date of Web Publication26-Dec-2011

Correspondence Address:
G Ankur
Unit 318, 1833 Riverside Drive, Ottawa, Ontario, K1G0E8
Canada
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-4065.86413

Rights and Permissions



How to cite this article:
Ankur G, Mohan B. Icodextrin and skin rash: Unusual presentation. Indian J Nephrol 2012;22:62-3

How to cite this URL:
Ankur G, Mohan B. Icodextrin and skin rash: Unusual presentation. Indian J Nephrol [serial online] 2012 [cited 2020 Nov 28];22:62-3. Available from: https://www.indianjnephrol.org/text.asp?2012/22/1/62/86413


We report a case of 50-year-old woman who was on continuous cyclic peritoneal dialysis (PD) with glucose exchanges. Her PD prescription was recently modified with an add-on last fill of icodextrin 7.5%. Four weeks later, she returned with generalized erythematous, itchy, maculopapular rash over the trunk and the back [Figure 1] and [Figure 2]. Laboratory results showed no signs of infection or inflammation. There was no other recent change in her diet and medications or a history of allergy or a skin disorder. Icodextrin was discontinued in view of chronology of this adverse reaction. In next 2 weeks, her rash disappeared. A similar presentation was seen in another woman who came with a similar presentation of rash, although seven weeks after icodextrin initiation and who also responded to stoppage of icodextrin. Furthermore, we found that both these patients had same lot number of icodextrin supplies. We, however, did not rechallenge our patients with icodextrin as it was neither ethically justified nor clinically indicated in absolute terms.
Figure 1: Photograph showing maculopapular rash over the trunk

Click here to view
Figure 2: Photograph showing maculopapular rash over the back

Click here to view


Icodextrin-based therapies have 10.1% incidence of rash compared with glucose regimes (4.6%, P value <0.003). [1] Our cases were unusual in two aspects. Rash were late-onset, whereas in most reports, rash occurred early within 3 weeks of icodextrin initiation. [1] Secondly, the rash generally involves palms and soles [1] which was spared in our cases.

The pathophysiology of cutaneous hypersensitivity to icodextrin is still unknown. It may be postulated that as icodextrin is constantly absorbed from lymphatics, it can induce immunosensitization. This maculopapular rash could be a distant manifestation of peritoneal immune process. Maltose, a metabolite of icodextrin, has a structural homology with dextran which is shown to cause nerve stimulation and pruritis in chronically exposed individuals. [2] The two polymers differ in their linkage of glucose molecules, α- 1,4 for icodextrin and α-1,6 for dextran. Dextran antibodies have been reported in PD patients. [3]

Though icodextrin is safe, it must be recognized as the possible cause of cutaneous hypersensitivity reactions. Nephrologists and dermatologists should be aware of this potential complication. A search for the icodextrin epitope causing this hypersensitivity should end the mystery.

 
  References Top

1.Wolfson M, Ogrinc F, Mujais S. Review of clinical trial experience with icodextrin. Kidney Int Suppl 2002;81:S46-52.  Back to cited text no. 1
[PUBMED]    
2.Bork K. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005;152:3-12.  Back to cited text no. 2
[PUBMED]  [FULLTEXT]  
3.Aanen MC, de Waart DR, Williams PF, Out TA, Zweers MM, Krediet RT. Dextran antibodies in peritoneal dialysis patients treated with icodextrin. Perit Dial Int 2002;22:513-5.  Back to cited text no. 3
[PUBMED]  [FULLTEXT]  


    Figures

  [Figure 1], [Figure 2]



 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07